MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 912938 Boston, MA

Position in BIO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,304,838

-$108,121,972 QoQ

Shares Held

7,850

-98.0% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#126

of 397 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 49% Shared 51% None 0%

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $5,155,670,910 across 15 Medical Devices names. BIO ranks #14 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDT	Medtronic plc	19,872,600	$1,554,633,495
2	ABT	Abbott Laboratories	13,359,956	$1,212,282,403
3	BSX	Boston Scientific Corp	24,859,191	$1,060,990,269
4	STE	STERIS plc	3,801,077	$800,392,779
5	DXCM	Dexcom Inc	3,560,621	$239,807,820
6	ITGR	Integer Holdings Corp	788,214	$73,658,598
7	SYK	Stryker Corp	195,835	$61,656,688
8	UFPT	Ufp Technologies Inc	223,474	$59,249,661

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,304,838	7,850	-98.0%	Shares	Defined	2026-08-03
2026-03-31	$110,426,810	396,150	-0.8%	Shares	Defined	2026-05-14
2025-12-31	$120,955,725	399,207	+4534.4%	Shares	Sole	2026-01-22
2025-09-30	$2,415,277	8,614	+131.2%	Shares	Sole	2025-10-29
2025-06-30	$899,157	3,726	-12.6%	Shares	Sole	2025-08-08
2025-03-31	$1,038,051	4,262	+18.5%	Shares	Sole	2025-05-02
2024-12-31	$1,181,649	3,597	-93.4%	Shares	Sole	2025-02-12
2024-09-30	$18,121,855	54,163	-84.5%	Shares	Sole	2024-11-12
2024-06-30	$95,189,757	348,540	+0.4%	Shares	Sole	2024-08-09
2024-03-31	$120,104,046	347,252	+7.7%	Shares	Sole	2024-05-14
2023-12-31	$104,065,509	322,294	-0.4%	Shares	Sole	2024-02-08
2023-09-30	$116,036,356	323,717	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.